Biovator

BIOVATOR’S IN-VITRO TESTING ALTERNATIVEON DISPLAY AT ICCA-LRI & JRC WORKSHOP

Wed, Jun 16, 2010 09:30 CET

For the first time, Sweden-based Biovator AB and its cooperation partners will reveal the crucial aspects of the company’s unique, animal-free testing method for human-specifi c allergenicity. A detailed presentation is being created for participants in the 2010 ICCA-LRI & JRC Workshop (International Council of Chemical Associations Long-Range Research Initiative), which will take place June 16-17, 2010 at the Grand Hotel Bristol in Stresa, Italy.Strong interest in animal-free testing is building due to ethical considerations as well as pending legislation. Already today, numerous

Biovator and BASF sign technology development agreement

Fri, Dec 18, 2009 11:30 CET

The Sweden-based biotech company Biovator and the global chemical industry leader BASF have signed a collaboration agreement for final development of In Vitro test systems capable of identifying the potential of chemical compounds to induce allergic reaction in humans. The agreement also includes a five-year BASF option of final product deliveries.“Allergic reactions to compounds are a serious risk in new products that needs to be discovered in the early stages of product development. This collaboration has the potential to open new dimensions in early industrial research that involves

Share

BIOVATOR’S IN-VITRO TESTING ALTERNATIVEON DISPLAY AT ICCA-LRI & JRC WORKSHOP

Biovator and BASF sign technology development agreement